Drug Topics November 19, 2024
Investigators said there is an imperative to optimize medication utilization and explore the consequences of medication burden on treatment outcomes in patients with long COVID.
The current approach to managing long COVID with medications largely targets nervous system symptoms and carries significant risks associated with polypharmacy and drug-drug interactions, according to recent research published in the Journal of the American Pharmacists Association.1 The authors of the study said the findings highlight the need to enhance the safety of long COVID symptom management.
About 7% of adults in the United States have reported ever having long COVID, according to data from the Medical Expenditure Panel Survey Household Component.2 The condition is defined as symptoms lasting 3 months or longer after the...
Today's Sponsors
Today's Sponsor